1
|
Bovi M, Carrizo ME, Capaldi S, Perduca M,
Chiarelli LR, Galliano M and Monaco HL: Structure of a lectin with
antitumoral properties in king bolete (Boletus edulis)
mushrooms. Glycobiology. 21:1000–1009. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Singh RS, Bhari R and Kaur HP: Mushroom
lectins: Current status and future perspectives. Crit Rev
Biotechnol. 30:99–126. 2010. View Article : Google Scholar : PubMed/NCBI
|
3
|
Yu L, Fernig DG, Smith JA, Milton JD and
Rhodes JM: Reversible inhibition of proliferation of epithelial
cell lines by Agaricus bisporus (edible mushroom) lectin.
Cancer Res. 53:4627–4632. 1993.PubMed/NCBI
|
4
|
Bovi M, Cenci L, Perduca M, Capaldi S,
Carrizo ME, Civiero L, Chiarelli LR, Galliano M and Monaco HL: BEL
β-trefoil: A novel lectin with antineoplastic properties in king
bolete (Boletus edulis) mushrooms. Glycobiology. 23:578–592.
2013. View Article : Google Scholar : PubMed/NCBI
|
5
|
Blyth K, Vaillant F, Jenkins A, McDonald
L, Pringle MA, Huser C, Stein T, Neil J and Cameron ER: Runx2 in
normal tissues and cancer cells: A developing story. Blood Cells
Mol Dis. 45:117–123. 2010. View Article : Google Scholar : PubMed/NCBI
|
6
|
Riminucci M, Corsi A, Peris K, Fisher LW,
Chimenti S and Bianco P: Coexpression of bone sialoprotein (BSP)
and the pivotal transcriptional regulator of osteogenesis,
Cbfa1/Runx2, in malignant melanoma. Calcif Tissue Int. 73:281–289.
2003. View Article : Google Scholar : PubMed/NCBI
|
7
|
Valenti MT, Zanatta M, Donatelli L,
Viviano G, Cavallini C, Scupoli MT and Carbonare L Dalle: Ascorbic
acid induces either differentiation or apoptosis in MG-63
osteosarcoma lineage. Anticancer Res. 34:1617–1627. 2014.PubMed/NCBI
|
8
|
Heid CA, Stevens J, Livak KJ and Williams
PM: Real time quantitative PCR. Genome Res. 6:986–994. 1996.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Kim DK, Kim DW, Kim SW, Kim DY, Lee CH and
Rhee CS: Ki67 antigen as a predictive factor for prognosis of
sinonasal mucosal melanoma. Clin Exp Otorhinolaryngol. 1:206–210.
2008. View Article : Google Scholar : PubMed/NCBI
|
10
|
Ivanov VN, Bhoumik A and Ronai Z: Death
receptors and melanoma resistance to apoptosis. Oncogene.
22:3152–3161. 2003. View Article : Google Scholar : PubMed/NCBI
|
11
|
Herr I and Debatin KM: Cellular stress
response and apoptosis in cancer therapy. Blood. 98:2603–2614.
2001. View Article : Google Scholar : PubMed/NCBI
|
12
|
Lu B, Wang L, Stehlik C, Medan D, Huang C,
Hu S, Chen F, Shi X and Rojanasakul Y: Phosphatidylinositol
3-kinase/Akt positively regulates Fas (CD95)-mediated apoptosis in
epidermal Cl41 cells. J Immunol. 176:6785–6793. 2006. View Article : Google Scholar : PubMed/NCBI
|
13
|
Boregowda RK, Olabisi OO, Abushahba W,
Jeong BS, Haenssen KK, Chen W, Chekmareva M, Lasfar A, Foran DJ,
Goydos JS, et al: RUNX2 is overexpressed in melanoma cells and
mediates their migration and invasion. Cancer Lett. 348:61–70.
2014. View Article : Google Scholar : PubMed/NCBI
|
14
|
Cohen-Solal KA, Boregowda RK and Lasfar A:
RUNX2 and the PI3K/AKT axis reciprocal activation as a driving
force for tumor progression. Mol Cancer. 14:1372015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Ott PA, Hodi FS and Buchbinder EI:
Inhibition of immune checkpoints and vascular endothelial growth
factor as combination therapy for metastatic melanoma: An overview
of rationale, preclinical evidence, and initial clinical data.
Front Oncol. 5:2022015. View Article : Google Scholar : PubMed/NCBI
|